Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.45 |
| ▸ | CA2 | P00918 | 6/20 | 0.45 |
| ▸ | CA12 | O43570 | 5/20 | 0.45 |
| ▸ | CA7 | P43166 | 5/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | APOB | P04114 | 10/20 | 0.43 |
| ▸ | MTTP | P55157 | 10/20 | 0.43 |
| ▸ | SMO | Q99835 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4231484 | 0.82 | CA1 (0.47) | CA1CA2CA12CA7CA14 | |
| SCHEMBL6199831 | 0.82 | CA1 (0.47) | CA1CA2CA12CA7CA14 | |
| SCHEMBL6198196 | 0.82 | CA1 (0.47) | CA1CA2CA12CA7CA14 | |
| Hydrochloric Acid SCHEMBL6203124 | 0.81 | CA1 (0.46) | CA1CA2CA12CA7CA14 | |
| Hydrochloric Acid SCHEMBL6203128 | 0.81 | CA1 (0.46) | CA1CA2CA12CA7CA14 | |
| SCHEMBL6196616 | 0.79 | APOB (0.45) | CA1CA2CA12CA7CA14 | |
| SCHEMBL6199303 | 0.79 | APOB (0.45) | CA1CA2CA12CA7CA14 | |
| SCHEMBL8765995 | 0.79 | MTNR1A (0.62) | CA1CA2CA12CA7CA14 | |
| SCHEMBL6502466 | 0.77 | MEN1 (0.55) | APOBMTTPMEN1KMT2A | |
| SCHEMBL30419785 | 0.76 | EPHX2 (0.48) | CA1CA2CA12CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001005767-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2001-01-25 | — | — | WO | disclosed |